Bellamkonda Ramesh, Rasineni Karuna, Singareddy Sreenivasa Reddy, Kasetti Ramesh Babu, Pasurla Ramatholisamma, Chippada Appa Rao, Desireddy Saralakumari
Department of Biochemistry, Sri Venkateswara University, Tirupati 517502, Andhra Pradesh, India.
Pathophysiology. 2011 Sep;18(4):255-61. doi: 10.1016/j.pathophys.2010.10.002. Epub 2011 Jul 20.
The present study investigated the effect of Commiphora mukul ethanol extract gum resin (CMEEt) on streptozotocin (STZ) induced diabetic rats by measuring fasting blood glucose, plasma insulin, plasma lipid profile, atherogenic index, hepatic lipid peroxidation (LPO), protein oxidation (PO) and activities of enzymatic antioxidants.
Wistar albino rats were divided into 4 groups, normal control group, CM-treated control group, diabetic control group and CM-treated diabetic group. For induction of diabetes, STZ was administered at a dose of 55mg/kg body weight, meanwhile CM-treated groups were administered CMEEt at a dose of 200mg/kg body weight for 60 days. Body weight, plasma glucose and insulin levels were determined in different experimental days, after end of the experimental period the plasma lipid profile and antioxidant enzymes were determined in hepatic tissue.
Increase in plasma glucose, total cholesterol (TC), triglycerides (TG), low density lipoprotein cholesterol (LDL-C), very low density lipoprotein cholesterol (VLDL-C), hepatic LPO and PO levels with decrease in plasma high density lipoprotein cholesterol (HDL-C), insulin, hepatic reduced glutathione (GSH) content and activities of antioxidant enzymes namely, glutathione peroxidase (GPX), glutathione reductase (GR), glutathione-S-transferase (GST), superoxide dismutase (SOD) and catalase (CAT) were the salient features observed in diabetic rats. On the other hand, oral administration of CMEEt at a dose of 200mg/kg for 60 days resulted in the prevention of above mentioned abnormalities.
The results suggest that CMEEt could be beneficial in the treatment of diabetes, characterized by atherogenous lipoprotein profile, aggravated antioxidant status and impaired glucose metabolism and in their prevention.
本研究通过测量空腹血糖、血浆胰岛素、血浆脂质谱、动脉粥样硬化指数、肝脏脂质过氧化(LPO)、蛋白质氧化(PO)以及酶促抗氧化剂的活性,研究没药乙醇提取物胶树脂(CMEEt)对链脲佐菌素(STZ)诱导的糖尿病大鼠的影响。
将Wistar白化大鼠分为4组,正常对照组、CM处理对照组、糖尿病对照组和CM处理糖尿病组。为诱导糖尿病,以55mg/kg体重的剂量给予STZ,同时以200mg/kg体重的剂量给予CM处理组CMEEt,持续60天。在不同实验日测定体重、血浆葡萄糖和胰岛素水平,实验期结束后测定肝脏组织中的血浆脂质谱和抗氧化酶。
糖尿病大鼠的显著特征为血浆葡萄糖、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、极低密度脂蛋白胆固醇(VLDL-C)、肝脏LPO和PO水平升高,同时血浆高密度脂蛋白胆固醇(HDL-C)、胰岛素、肝脏还原型谷胱甘肽(GSH)含量以及抗氧化酶即谷胱甘肽过氧化物酶(GPX)、谷胱甘肽还原酶(GR)、谷胱甘肽-S-转移酶(GST)、超氧化物歧化酶(SOD)和过氧化氢酶(CAT)的活性降低。另一方面,以200mg/kg的剂量口服CMEEt 60天可预防上述异常情况。
结果表明,CMEEt可能对以动脉粥样硬化脂蛋白谱、抗氧化状态加重和糖代谢受损为特征的糖尿病治疗及其预防有益。